Pharmaterials Overview
- Founded
- 2000

- Status
- Acquired/Merged
- Employees
- 38

- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 2
Pharmaterials General Information
Description
Provider of medical contract development and manufacturing services. The company uses 13 GMP manufacturing suites to offer characterization and optimization of drug substance physical forms, development of preclinical and clinical formulations, clinical trial manufacturing and global drug product supply services in the United Kingdom.
Contact Information
- Unit B, 5 Boulton Road
- Reading RG2 0NH
- England, United Kingdom
Pharmaterials Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Pharmaterials‘s full profile, request access.
Request a free trialPharmaterials Comparisons
Industry
0000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialPharmaterials Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Kuecept | Formerly PE-Backed | Potters Bar, United Kingdom | 00 | 000000000000 | ||
00000000 00000000 | Corporate Backed or Acquired | College Station, TX | 000 | 0000000000 | ||
000000 | Private Equity-Backed | Clearwater, FL | 000 | 0000 | 000000 - 000 | |
000 000000 0000000 | Private Equity-Backed | Philadelphia, PA | 0000 | 00000 | 000000000 | 00000 |
000 000000000 | Formerly VC-backed | Durham, NC | 0000 | 0000 | 000000&0 | 0000 |
Pharmaterials Patents
Pharmaterials Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20130177651-A1 | Pharmaceutical composition suitable for use in a dry powder inhaler | Abandoned | 03-Sep-2010 | 000000000 | 0 |
EP-2611416-B1 | Pharmaceutical composition suitable for use in a dry powder inhaler | Expired - Fee Related | 03-Sep-2010 | 000000000 | |
EP-2611416-A1 | Pharmaceutical composition suitable for use in a dry powder inhaler | Granted | 03-Sep-2010 | A61K47/28 |
Pharmaterials Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPharmaterials Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Pharmaterials‘s full profile, request access.
Request a free trial